Showing results (301-310 of 435) with videos related to
Sort By:
Pageof 44
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 4, 2012
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditionsRajamannar Ramasubbu, Valerie H Taylor, Zainab Samaan, et al.Leukemia Research|March 16, 2013
Symptom burden and supportive care in patients with acute leukemiaCamilla Zimmermann, Dora Yuen, Ashley Mischitelle, et al.Psycho-Oncology|January 30, 2015
Distancing, self-esteem, and subjective well-being in head and neck cancerGerald M Devins, Janice C Wong, Ada Y M Payne, et al.Plos One|July 17, 2026
Content validity of the quality of dying and death questionnaire- revised global-version in North American inpatient hospicesAlyssa E Tilly, Jared E Lowe, Mary Goombs, et al.Palliative & Supportive Care|August 17, 2022
Measuring and understanding death anxiety in caregivers of patients with primary brain tumorKelcie Willis, Scott G Ravyts, Autumn Lanoye, et al.Psycho-Oncology|April 11, 2026
Managing Cancer and Living Meaningfully (CALM) for Patients With Metastatic Cancer and Treatment ResponseFroukje E de Vries, Emma Hafkamp, Anne Huisman, et al.BMJ Open|March 24, 2021
Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocolEmily Beswick, Stella A Glasmacher, Rachel Dakin, et al.Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|January 28, 2017
Psychiatric symptomatology after delirium: a systematic reviewClare Langan, Deep P Sarode, Tom C Russ, et al.Clinical Psychology Review|June 21, 2024
Stigma in functional neurological disorder (FND) - A systematic reviewCaoimhe McLoughlin, Laura McWhirter, Katerina Pisegna, et al.The British Journal of Psychiatry : the Journal of Mental Science|April 4, 2006
Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trialTony Kendrick, Robert Peveler, Louise Longworth, et al.Pageof 44